You are here: Industry Insights > WHO

News List

Sinovac COVID-19 vaccine gets WHO validation for emergency use expresspharma
June 02, 2021
WHO’s Emergency Use Listing (EUL) is a prerequisite for COVAX Facility vaccine supply and international procurement.
Africa urgently needs 20 million second doses of COVID-19 vaccine worldpharmanews
May 28, 2021
Africa needs at least 20 million doses of the Oxford-AstraZeneca vaccine in the next six weeks to get second doses to all who received a first dose within the 8 - 12-week interval between doses recommended by the World Health Organization (WHO).
Johnson & Johnson to donate 200,000 vaccine regimens to curb Ebola outbreak europeanpharmaceuticalreview
May 18, 2021
To prevent the spread of the Ebola virus in West Africa, Johnson & Johnson is donating vaccines for a WHO early access clinical programme.
ICMRA and WHO state clinical trial reports should be published without redaction europeanpharmaceuticalreview
May 11, 2021
The International Coalition of Medicines Regulatory Authorities (ICMRA) and WHO are calling on pharma to provide voluntary unrestricted access to trial results data.
WHO grants Sinopharm’s COVID-19 vaccine emergency approval pharmatimes
May 11, 2021
The World Health Organization (WHO) has approved Sinopharm’s COVID-19 vaccine for emergency use, making it the first jab developed by a non-Western company to gain this recommendation.
COVID strain identified in India is ‘variant of concern’: WHO expresspharma
May 11, 2021
There is some available information to suggest increased transmissibility of B-1617, said Dr Maria Van Kerkhove, COVID-19 Technical Lead at the World Health Organisation (WHO).
$150 million made available for COVID-19 vaccine adverse event compensation scheme europeanpharmaceuticalreview
May 06, 2021
The COVAX No-fault Compensation Program will offer individuals in 92 lower-income countries and economies compensation for serious adverse events associated with COVID-19 vaccines distributed through COVAX.
Moderna receives emergency use listing from WHO for Covid-19 vaccine pharmaceutical-technology
May 06, 2021
Moderna has received emergency use listing (EUL) from the World Health Organization (WHO) for its Covid-19 vaccine to prevent the disease in individuals aged 18 years and above.
WHO: 90 Percent of Countries' Health Services Continue to be Disrupted by the COVID-19 Pandemic americanpharmaceuticalreview
April 27, 2021
There are some signs of progress however: in 2020, countries surveyed reported that, on average, about half of essential health services were disrupted. In the first 3 months of 2021, that figure had dropped to just over one third of services.
WHO recommends against ivermectin for COVID-19 expresspharma
April 02, 2021
The World Health Organization (WHO) on Wednesday recommended against using generic anti-parasite drug ivermectin in patients with COVID-19 except for clinical trials, because of a lack of data demonstrating its benefits.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page